Clinical Trial Update: PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain [Phase 3]

View source ↗

Summary

Phase 3 trial comparing patient-controlled analgesia vs non-PCA intravenous hydromorphone titration for severe cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Hydromorphone (hydromorphone)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Cancer Pain | Phase 3 | Status: COMPLETED